Key result
Molecular genetics has unraveled the molecular bases of hypertrophic cardiomyopathy through mutations in sarcomeric proteins, impacting disease understanding and clinical management.
Population
Patients with hypertrophic cardiomyopathy and their relatives
Design
Review
Authors
Loading...
May inform individualized HCM management; leaves open prospective validation of genetic testing benefits.
This review highlights the role of molecular genetic testing in understanding hypertrophic cardiomyopathy and its emerging impact on individualized patient management.
Charron et al. (2005) conducted a review in Hypertrophic cardiomyopathy. Molecular testing was evaluated. Molecular genetics has unraveled the molecular bases of hypertrophic cardiomyopathy through mutations in sarcomeric proteins, impacting disease understanding and clinical management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: